Machine perfusion of deceased donor kidneys has been shown to improve graft performance. The randomised European multicentre trial published in the New England Journal of Medicine clearly proved beyond doubt the beneficial effect of machine perfusion on delayed graft function.¹

In February 2012, the Agence de la Biomédecine in France announced the introduction of a national program for machine perfusion of all ECD kidneys.

LifePort has been introduced into six centers in Brazil to date, with routine use of the machine employed at major transplant hospitals in Fortaleza and Rio. Several leading transplant hospitals in São Paulo have also recently initiated machine perfusion of kidneys with LifePort.